Switzerland · Series B startup

Who invested in Aurealis Pharma

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$7.8Mraised across 1 round since 2019, from 1 source

Latest round
Series B, $7.8MFeb 2019
Investors
2
See who backed them

The rounds

  1. Feb 2019

Everyone who backed them

Business FinlandAccelerator1round
Finnvera Venture CapitalGovernment1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Aurealis Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Nostetta LtdVC firmPer its own site

Quick answers about Aurealis Pharma

Who invested in Aurealis Pharma?

Aurealis Pharma's investors include Business Finland and Finnvera Venture Capital.

How much has Aurealis Pharma raised?

Aurealis Pharma has raised $7.8M across 1 round since 2019.

When did Aurealis Pharma last raise?

Aurealis Pharma's most recent round was a Series B of $7.8M in Feb 2019.

What was Aurealis Pharma's biggest round?

Its most recent round, $7.8M in Feb 2019, is also its largest on record.

Who backed Aurealis Pharma first?

Aurealis Pharma's first round on record, in Feb 2019, was backed by Business Finland and Finnvera Venture Capital.

What stage is Aurealis Pharma at?

Aurealis Pharma's latest named round is a Series B, in Feb 2019.

Where is Aurealis Pharma based?

Aurealis Pharma is based in Switzerland.

Companies like Aurealis Pharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.